Showing results (161-170 of 204) with videos related to

Sort By:
Pageof 21
Pharmacology|January 1, 1993
RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agentD Amin, S K Gustafson, J M Weinacht, et al.
Biopharmaceutics & Drug Disposition|July 1, 1994
The bioavailability and nonlinear pharmacokinetics of MK-679 in humansH Cheng, J I Schwartz, C Lin, et al.
American Heart Journal|August 1, 1988
Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responsesB F Uretsky, J A Shaver, C S Liang, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Midline Assembloids Reveal Regulators of Human Axon GuidanceMassimo M Onesto, Neal D Amin, Chenjie Pan, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 1997
Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302)J M Glover, J M Leeds, T G Mant, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1994
Metabolic disposition of simvastatin in patients with T-tube drainageH Cheng, M S Schwartz, S Vickers, et al.
Clinical Pharmacology and Therapeutics|November 5, 1999
Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsJ D Rogers, J Zhao, L Liu, et al.
Journal of Internal Medicine|April 18, 2018
Hyponatremia and activation of vasopressin secretion are both independently associated with 30-day mortality: results of a multicenter, observational studyA Eckart, P Hausfater, D Amin, et al.
Nanoscale|August 14, 2019
Quantum capacitance-limited MoS2 biosensors enable remote label-free enzyme measurementsSon T Le, Nicholas B Guros, Robert C Bruce, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 27, 2005
Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthmaZ Diamant, J Kuperus, R Baan, et al.
Pageof 21